Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

CVS Health Corporation (CVS) — XLV Health Care · S&P 500 Profile |CVS 健康公司介紹

health-careS&P500xlvxlv-top-25
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

CVS Health Corporation (CVS) — Business, History & S&P 500 Profile |CVS 健康公司介紹

CVS Health company profile · pharmacy, health benefits and health services · history · financial snapshot · S&P 500 rank #116 · CVS 健康公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Nov 5, 2026 (Slickcharts)
Financials: FY2025 (ended Dec 31, 2025)
MARKET CAP
$102.71B
Nov 5, 2026 · Slickcharts
S&P 500 WEIGHT
0.15%
Rank #116 · Nov 5, 2026 (Slickcharts)
FY2025 TOTAL REVENUES
$402.07B
+7.8% YoY · Record high
FY2025 NET INCOME
$1.73B
Attributable to CVS Health · Diluted EPS $1.39 · After a $5.7B Health Services goodwill impairment

SNAPSHOT

TickerCVS (NYSE)
CompanyCVS Health Corporation
GICS sector / industryHealth Care / Health Care Services
S&P 500 rank (by weight)#116 · 0.15% (Nov 5, 2026)
Sector rank (by S&P 500 weight)#20 in Health Care (Nov 5, 2026)
HeadquartersWoonsocket, Rhode Island
Founded1963, founded in Lowell, Massachusetts, as Consumer Value Stores by Sidney and Stanley Goldstein and Ralph Hoagland
CEOJ. David Joyner (president & CEO, since Oct 2024)
Employees>300,000 colleagues (FY2025 10-K)
Market cap$102.71B (Nov 5, 2026)
SEC filingsEDGAR — CIK 0000064803

WHAT IT DOES

CVS Health Corporation is an integrated health-care company that combines a health insurer (Aetna), a pharmacy benefit manager and care-delivery businesses (CVS Caremark, Signify Health, Oak Street Health), and the largest U.S. retail pharmacy chain. It reports three operating segments — Health Care Benefits, Health Services and Pharmacy & Consumer Wellness — plus Corporate/Other. At December 31, 2025, it operated approximately 9,000 retail locations and more than 1,000 walk-in and primary-care clinics; its PBM served approximately 87 million plan members and its insurance business more than 37 million people.

FY2025 total revenues were a record $402.07B, up 7.8% year on year — products $249.91B, premiums $134.75B, services $15.18B and net investment income $2.23B. Profit went the other way: operating income fell to $4.66B from $8.52B, and net income attributable to CVS Health was $1.73B, or $1.39 per diluted share (adjusted EPS $6.75), after a $5.7B goodwill impairment in Health Services. Adjusted operating income was $14.44B, up from $11.98B.

Segment total revenues before intersegment eliminations were $190.43B in Health Services, $143.35B in Health Care Benefits and $139.37B in Pharmacy & Consumer Wellness. The model is vertical integration: the insurer directs members to the PBM, the PBM directs prescriptions to the pharmacies and clinics, and each leg’s economics depend on the others’ cost assumptions — above all medical-cost trends in the insurance book.

SEGMENTS — FY2025 TOTAL REVENUES

SegmentRevenuesShareYoY
Health Services$190.43B40.2%+9.7%
Health Care Benefits$143.35B30.3%+9.7%
Pharmacy & Consumer Wellness$139.37B29.4%+12.0%
Corporate/Other$0.48B0.1%+7.3%
Segment total revenues as disclosed in the FY2025 10-K, before intersegment eliminations; the four rows total $473.63B and reconcile to consolidated total revenues of $402.07B after eliminations of about $71.56B (chiefly Pharmacy & Consumer Wellness sales to Health Services customers). Shares are of the segment total. FY2024 comparatives: Health Services $173.61B, Health Care Benefits $130.67B, Pharmacy & Consumer Wellness $124.50B, total revenues $372.81B.

HISTORY

YearMilestone
1963Consumer Value Stores is founded in Lowell, Massachusetts, by Sidney and Stanley Goldstein and Ralph Hoagland, as a health and beauty aids store.
1969The initials CVS are used for the first time in the company’s logo.
2007CVS completes its merger with Caremark Rx, creating CVS Caremark and adding pharmacy benefit management at national scale.
2018CVS completes its acquisition of Aetna on November 28, 2018, combining pharmacy, PBM and health insurance.
2024J. David Joyner becomes president and CEO in October 2024.

COMPETITIVE POSITION

  • The only fully integrated U.S. health-care major: it competes with UnitedHealth (insurer plus Optum) on the integrated model, with Cigna and Humana in insurance, with Cencora-linked and independent PBMs in benefit management, and with Walgreens and Walmart in retail pharmacy.
  • Medical-cost trend is the swing factor: Health Care Benefits adjusted operating income fell in 2025 on Medicare cost pressure and programme changes under the Inflation Reduction Act, even as group adjusted operating income rose to $14.44B.
  • The $5.7B Health Services goodwill impairment is the market’s warning label: acquisition-built goodwill (Oak Street, Signify) is being written down where care-delivery cash flows undershoot the prices paid.

FINANCIAL SNAPSHOT — FY2025

Total revenues$402.07B
Operating income$4.66B
Adjusted operating income (non-GAAP)$14.44B
Net income attributable to CVS Health$1.73B
Diluted EPS$1.39
Adjusted EPS (non-GAAP)$6.75
FY2025 ended Dec 31, 2025; Form 10-K filed Feb 10, 2026 (accession 0000064803-26-000010). Prior-year figures: total revenues $372.81B, operating income $8.52B, net income attributable to CVS Health $4.59B, diluted EPS $3.66, adjusted EPS $5.42, so total revenues grew 7.8% while diluted EPS fell $2.27 (as reported in the FY2025 results). Cash flow from operations was $10.6B.

KEY RISKS

  • Medical-cost risk: Medicare Advantage and Part D cost trends and programme redesign under the Inflation Reduction Act directly set Health Care Benefits margins; 2025 showed how fast they can compress.
  • Goodwill and integration risk: the $5.7B Health Services impairment in 2025 may not be the last if Oak Street and Signify cash flows stay below plan.
  • PBM regulatory risk: federal and state moves on rebate pass-through, spread pricing and PBM transparency target the Health Services profit pool directly.
  • Retail pharmacy risk: front-store sales keep migrating online, reimbursement pressure squeezes pharmacy margins, and the store base carries opioid-litigation and labour-cost exposure.

WHY IT MATTERS FOR THE S&P 500

CVS is the S&P 500’s integrated health-care bellwether: its medical-cost trends, PBM volumes and pharmacy scripts read as a gauge of U.S. health-care consumption and of whether vertical integration in health care actually pays. At rank #116 by weight (0.15%) — Health Care #20 — it pairs one of the index’s largest revenue lines with one of its most contested earnings stories.

SOURCES & METHODOLOGY

Market dataSlickcharts S&P 500 by weight (rank, weight, price, market cap — Nov 5, 2026 crawl, single source)
FinancialsForm 10-K for FY2025 (year ended Dec 31, 2025), filed Feb 10, 2026
Sector classificationGICS via the List of S&P 500 companies (Wikipedia)
Library dataSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

CVS Health

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

股票代號CVS(NYSE)
公司CVS Health Corporation
GICS 板塊/行業健康護理/Health Care Services
標普500排名(按權重)第116名 · 0.15%(2026 年 11 月 5 日)
板塊內排名(按標普500權重)健康護理第20名(2026 年 11 月 5 日)
總部羅得島州文索基特
成立1963年,由 Sidney 及 Stanley Goldstein 與 Ralph Hoagland 於麻省洛厄爾創立,初名 Consumer Value Stores
行政總裁J. David Joyner(總裁兼行政總裁,自2024年10月起)
員工超過300,000名員工(FY2025 10-K)
市值$102.71B(2026 年 11 月 5 日)
SEC 文件EDGAR — CIK 0000064803

業務概覽

CVS 健康公司是一家綜合健康護理公司,結合了健康保險商(Aetna)、藥品福利管理及醫療服務業務(CVS Caremark、Signify Health、Oak Street Health),以及美國最大的零售藥房連鎖。公司報告三個經營板塊——Health Care Benefits、Health Services 及 Pharmacy & Consumer Wellness——另加 Corporate/Other。截至2025年12月31日,公司經營約9,000個零售點及超過1,000間免預約及基層醫療診所;其 PBM 服務約8,700萬名計劃成員,保險業務服務超過3,700萬人。

FY2025 總收入創紀錄達4,020.7億美元,同比增長7.8%——產品2,499.1億美元、保費1,347.5億美元、服務151.8億美元及淨投資收入22.3億美元。利潤則背道而馳:營運利潤由85.2億美元跌至46.6億美元,歸屬於 CVS 健康的淨利潤為17.3億美元,攤薄每股收益1.39美元(經調整每股收益6.75美元),此前 Health Services 錄得57億美元的商譽減值。經調整營運利潤為144.4億美元,去年為119.8億美元。

未計板塊間抵銷的板塊總收入分別為:Health Services 1,904.3億美元、Health Care Benefits 1,433.5億美元、Pharmacy & Consumer Wellness 1,393.7億美元。其模式是垂直整合:保險商將成員引導至 PBM,PBM 將處方引導至藥房及診所,而每一環的經濟效益都取決於其他環節的成本假設——尤其是保險業務的醫療成本趨勢。

板塊 — FY2025 總收入

板塊收入佔比同比
Health Services1,904.3億美元40.2%+9.7%
Health Care Benefits1,433.5億美元30.3%+9.7%
Pharmacy & Consumer Wellness1,393.7億美元29.4%+12.0%
Corporate/Other4.8億美元0.1%+7.3%
板塊總收入按 FY2025 10-K 披露,未計板塊間抵銷;四行合計4,736.3億美元,經約715.6億美元的抵銷(主要為 Pharmacy & Consumer Wellness 向 Health Services 客戶的銷售)後,與綜合總收入4,020.7億美元對賬。佔比以板塊總額為基礎。FY2024 比較數字:Health Services 1,736.1億美元,Health Care Benefits 1,306.7億美元,Pharmacy & Consumer Wellness 1,245.0億美元,總收入3,728.1億美元。

歷史沿革

年份里程碑
1963年Consumer Value Stores 由 Sidney 及 Stanley Goldstein 與 Ralph Hoagland 於麻省洛厄爾創立,起初為健康及美容用品店。
1969年CVS 縮寫首次用於公司標誌。
2007年CVS 完成與 Caremark Rx 的合併,組成 CVS Caremark,並取得全國規模的藥品福利管理業務。
2018年CVS 於2018年11月28日完成收購 Aetna,將藥房、PBM 及健康保險結合。
2024年J. David Joyner 於2024年10月出任總裁兼行政總裁。

競爭地位

  • 美國唯一完全整合的健康護理大型企業:在整合模式上與 UnitedHealth(保險加 Optum)競爭,在保險方面與 Cigna 及 Humana 競爭,在福利管理方面與其他 PBM 競爭,在零售藥房方面與 Walgreens 及 Walmart 競爭。
  • 醫療成本趨勢是關鍵變數:Health Care Benefits 的經調整營運利潤於2025年因 Medicare 成本壓力及《降低通脹法案》下的計劃變化而下跌,儘管集團經調整營運利潤升至144.4億美元。
  • Health Services 的57億美元商譽減值是市場的警示:以收購建立的商譽(Oak Street、Signify)在醫療服務現金流低於收購價所依據的預期時正被撇減。

財務快照 — FY2025

總收入4,020.7億美元
營運利潤46.6億美元
經調整營運利潤(非 GAAP)144.4億美元
歸屬於 CVS 健康的淨利潤17.3億美元
攤薄每股收益1.39美元
經調整每股收益(非 GAAP)6.75美元
FY2025 截至2025年12月31日;10-K 於2026年2月10日提交(accession 0000064803-26-000010)。上年數字:總收入3,728.1億美元,營運利潤85.2億美元,歸屬於 CVS 健康的淨利潤45.9億美元,攤薄每股收益3.66美元,經調整每股收益5.42美元,故總收入增長7.8%,而攤薄每股收益下跌2.27美元(按 FY2025 業績報告)。經營現金流為106億美元。

主要風險

  • 醫療成本風險:Medicare Advantage 及 Part D 的成本趨勢,以及《降低通脹法案》下的計劃重新設計,直接決定 Health Care Benefits 的利潤;2025年顯示了其壓縮速度之快。
  • 商譽及整合風險:若 Oak Street 及 Signify 的現金流持續低於計劃,2025年 Health Services 的57億美元減值未必是最後一次。
  • PBM 監管風險:聯邦及州政府就回扣轉付、差價定價及 PBM 透明度的措施,直接針對 Health Services 的利潤池。
  • 零售藥房風險:前店銷售持續轉向線上,報銷壓力擠壓藥房利潤,門店基礎亦面臨阿片類訴訟及勞工成本風險。

對標普500的重要性

CVS 是標普500中綜合健康護理的風向標:其醫療成本趨勢、PBM 業務量及藥房處方量,可反映美國健康護理消費,以及健康護理垂直整合是否真正奏效。按權重排名第116位(0.15%)——健康護理第20名——它同時擁有指數中最大的收入線之一及最受爭議的盈利故事之一。

來源與方法

市場數據Slickcharts 標普500權重榜(排名、權重、價格、市值——2026 年 11 月 5 日抓取,單一來源)
財務FY2025 10-K(截至2025年12月31日的年度),2026年2月10日提交
板塊分類GICS,據 S&P 500 公司清單(Wikipedia)
圖庫數據SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

CVS Health

來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · CVS
Data as of Nov 5, 2026 · Financials FY2025 (10-K) · Market data Nov 2026
Previous · Vulcan Materials Company (VMC) — XLB Materials · S&P 500 Profile |火神材料公司介紹Next · Automatic Data Processing, Inc. (ADP) — XLI Industrials · S&P 500 Profile |自動數據處理公司介紹

Entered 2026-11-04 17:16 · updated 2026-11-14 23:15 · rev 5